These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25547334)

  • 1. Cost-utility analyses of cognitive-behavioural therapy of depression: a systematic review.
    Brettschneider C; Djadran H; Härter M; Löwe B; Riedel-Heller S; König HH
    Psychother Psychosom; 2015; 84(1):6-21. PubMed ID: 25547334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic evaluation of an augmented cognitive behavioural intervention vs. computerized cognitive training for post-stroke depressive symptoms.
    van Eeden M; Kootker JA; Evers SM; van Heugten CM; Geurts AC; van Mastrigt GA
    BMC Neurol; 2015 Dec; 15():266. PubMed ID: 26715040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.
    Richards DA; Ekers D; McMillan D; Taylor RS; Byford S; Warren FC; Barrett B; Farrand PA; Gilbody S; Kuyken W; O'Mahen H; Watkins ER; Wright KA; Hollon SD; Reed N; Rhodes S; Fletcher E; Finning K
    Lancet; 2016 Aug; 388(10047):871-80. PubMed ID: 27461440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the cost-effectiveness of pharmacotherapy compared with cognitive-behavioural therapy and combination therapy for the treatment of moderate to severe depression in the UK.
    Koeser L; Donisi V; Goldberg DP; McCrone P
    Psychol Med; 2015 Oct; 45(14):3019-31. PubMed ID: 26040631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic Evaluation of Cognitive Behavioral Therapy for Depression: A Systematic Review.
    Li M; Bai F; Yao L; Qin Y; Chen K; Xin T; Ma X; Ma Y; Zhou Y; Dai H; Li R; Li X; Yang K
    Value Health; 2022 Jun; 25(6):1030-1041. PubMed ID: 35422392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic Impact of Third-Wave Cognitive Behavioral Therapies: A Systematic Review and Quality Assessment of Economic Evaluations in Randomized Controlled Trials.
    Feliu-Soler A; Cebolla A; McCracken LM; D'Amico F; Knapp M; López-Montoyo A; García-Campayo J; Soler J; Baños RM; Pérez-Aranda A; Andrés-Rodriguez L; Rubio-Valera M; Luciano JV
    Behav Ther; 2018 Jan; 49(1):124-147. PubMed ID: 29405918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of In-Home Cognitive Behavioral Therapy for low-income depressed mothers participating in early childhood prevention programs.
    Ammerman RT; Mallow PJ; Rizzo JA; Putnam FW; Van Ginkel JB
    J Affect Disord; 2017 Jan; 208():475-482. PubMed ID: 27838144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depression.
    Vos T; Corry J; Haby MM; Carter R; Andrews G
    Aust N Z J Psychiatry; 2005 Aug; 39(8):683-92. PubMed ID: 16050922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of alternative treatments for depression in low-income women.
    Beil H; Beeber LS; Schwartz TA; Lewis G
    J Ment Health Policy Econ; 2013 Jun; 16(2):55-65. PubMed ID: 23999203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial.
    Watanabe N; Furukawa TA; Shimodera S; Katsuki F; Fujita H; Sasaki M; Sado M; Perlis ML
    Psychiatry Clin Neurosci; 2015 Jun; 69(6):335-43. PubMed ID: 25205008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analyses of drug therapies in breast cancer: a systematic review.
    Nerich V; Saing S; Gamper EM; Kemmler G; Daval F; Pivot X; Holzner B
    Breast Cancer Res Treat; 2016 Oct; 159(3):407-24. PubMed ID: 27572551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of cognitive behavioural therapy and selective serotonin reuptake inhibitors for major depression in children and adolescents.
    Haby MM; Tonge B; Littlefield L; Carter R; Vos T
    Aust N Z J Psychiatry; 2004 Aug; 38(8):579-91. PubMed ID: 15298580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
    Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
    J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial protocol.
    Ferrari GR; Becker ES; Smit F; Rinck M; Spijker J
    BMC Psychiatry; 2016 Nov; 16(1):370. PubMed ID: 27809880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial.
    Safren SA; Bedoya CA; O'Cleirigh C; Biello KB; Pinkston MM; Stein MD; Traeger L; Kojic E; Robbins GK; Lerner JA; Herman DS; Mimiaga MJ; Mayer KH
    Lancet HIV; 2016 Nov; 3(11):e529-e538. PubMed ID: 27658881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological Treatment of Depression in People Aged 65 Years and Over: A Systematic Review of Efficacy, Safety, and Cost-Effectiveness.
    Jonsson U; Bertilsson G; Allard P; Gyllensvärd H; Söderlund A; Tham A; Andersson G
    PLoS One; 2016; 11(8):e0160859. PubMed ID: 27537217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group psychological therapies for depression in the community: systematic review and meta-analysis.
    Huntley AL; Araya R; Salisbury C
    Br J Psychiatry; 2012 Mar; 200(3):184-90. PubMed ID: 22383765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.
    Snedecor SJ; Botteman MF; Schaefer K; Sarocco P; Barry N; Pickard AS
    J Ment Health Policy Econ; 2010 Mar; 13(1):27-35. PubMed ID: 20571180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of multidimensional family therapy compared to cognitive behavioral therapy for adolescents with a cannabis use disorder: Data from a randomized controlled trial.
    Goorden M; van der Schee E; Hendriks VM; Hakkaart-van Roijen L
    Drug Alcohol Depend; 2016 May; 162():154-61. PubMed ID: 27006273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis for antidepressants and cognitive behavioral therapy for major depression in Thailand.
    Prukkanone B; Vos T; Bertram M; Lim S
    Value Health; 2012; 15(1 Suppl):S3-8. PubMed ID: 22265064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.